The audacity of hope: nations prepare for advent of vaccines
With viable Covid-19 vaccines just over the horizon, the work is under way creating distribution networks – and negotiating legalities and prices
Tom Chivers got his Covid-19 vaccine way back in July.
Well, he might have. As a participant in the Oxford–AstraZeneca Covid-19 vaccine trial, the British science journalist was one of thousands who received either the actual vaccine during the summer, or a placebo.
“They gave me the jab and I had to just sit there for 20 minutes to make sure I didn’t go into anaphylactic shock,” Chivers told the Business Post. “The...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
More than 400 children taken into state care in first half of 2020
There are now almost 6,000 children in care in Ireland
Susan O’Keeffe: Missed cancer diagnoses hint at true toll of fight against Covid-19
Stark figures act as a flag for every other medical condition that has been ignored, downplayed, downgraded and sidestepped since the pandemic was declared
De Gascun: negative result not passport to ignore advice
The director of the National Virus Reference Laboratory warns coronavirus may not show up on a test for one or two days if people have already caught it from their travels
HSE spent €740,000 refurbishing headquarters over past three years
Leasing alternative office space to that at Dr Steevens’ Hospital would cost ‘between €4.5 million and €9.5 million a year’